Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07106151 · ClinicalTrials.gov registry record · NA
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2
A NA study of AKI and AKI - Acute Kidney Injury, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07106151: Recruiting NA study of AKI and AKI - Acute Kidney Injury, sponsored by University of California, San Francisco.
NCT07106151 is a NA study of AKI and AKI - Acute Kidney Injury that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 40 participants, below the 82-participant average among 4 other AKI trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07106151, a NA study of AKI and AKI - Acute Kidney Injury, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Providing additional information to patients with acute kidney injury who continue dialysis after hospital discharge and to the accepting kidney doctor (nephrologist) who manages their dialysis may be feasible and beneficial. This study will pilot measuring the patient's residual kidney function at the time of discharge and communicating that result to the accepting nephrologist and the patient, along with information on recommended recovery monitoring frequency and criteria for consideration of a twice-weekly hemodialysis schedule.
Conditions Studied
Interventions
- BEHAVIORAL Transmission of additional AKI-D recovery information
- OTHER No additional AKI-D recovery information
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-02-23 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT07106151 shows while recruiting
NCT07106151 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 82-participant average among 4 other AKI trials with a reported enrollment target (51% lower).
The record links to 3 conditions, with AKI appearing as the primary indexed condition, and to 2 interventions - of which Transmission of additional AKI-D recovery information is the first listed.
NCT07106151 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07106151 about?
NCT07106151 is a clinical study titled "Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2". Providing additional information to patients with acute kidney injury who continue dialysis after hospital discharge and to the accepting kidney doctor (nephrologist) who manages their dialysis may be feasible and beneficial. This study will pilot measuring the patient's residual kidney function at ...
What is the current status of trial NCT07106151?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-02-23. Estimated completion is 2028-01.
What conditions does trial NCT07106151 study?
This clinical trial studies the following conditions: AKI, AKI - Acute Kidney Injury, Dialysis Patients.
What interventions are being tested in trial NCT07106151?
The interventions under investigation include: Transmission of additional AKI-D recovery information (BEHAVIORAL), No additional AKI-D recovery information (OTHER).
Who is sponsoring clinical trial NCT07106151?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07106151 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for AKI
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NO During CPB in Neonates to Reduce Risk of AKI
RECRUITING · Phase 3
-
Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery
COMPLETED · Phase 2
-
Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study
COMPLETED
-
Protection From Acute Kidney Injury (AKI) With Basis™ Treatment
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI